Specifically, we discover that oxPPP-derived NADPH is necessary to drive the reactions catalyzed by TRXR and GSR, identifying inhibition of the PRPS1 isoform as a new potential therapeutic angle to sensitize cells to toxic levels of oxidative stress in these lymphomas. The gene discussed is GSR; the disease is lymphoma.